Article
Cross-serotypically conserved epitope recommendations for a universal T cell-based dengue vaccine
21 Sept 2020
Abstract excerpt
Dengue virus (DENV)-associated disease is a growing threat to public health across the globe. Co-circulating as four different serotypes, DENV poses a unique challenge for vaccine design as immunity to one serotype predisposes a person to severe and potentially lethal disease upon infection from other serotypes. Recent experimental studies suggest that an effective vaccine against DENV should elicit a strong T...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
